Skip to main content
. 2022 May;43(5):682–688. doi: 10.3174/ajnr.A7477

Table 1:

Clinical and demographic summary for study samplea

Overall GBM NGG Other
No. of subjects 44 32 10 2
Age (yr) 60.2 (13.7) 62.4 (11.6) 50.3 (15.3) 75.5 (13.4)
Overall survival (mo) 40.4 (61.5) 35.3 (64.9) 64.3 (46.1) 2.0 (0)
Radiation treatment (y/n) 39/5 29/3 10/0 0/2
Chemotherapy (y/n) 40/4 30/2 10/0 0/2
Tumor-treating fields (y/n) 28/16 16/16 0/10 0/2
Other treatment (y/n) 7/37 5/27 2/8 0/2
Time between last MR imaging and death (days) 63.0 (62.1) 49.6 (42.3) 111.8 (93.1) 33.0 (13.4)

Note:—Y/n indicates yes/no.

a

Quantitative values are presented as mean (SD).